Characteristics and outcomes of psychiatric inpatients with severe mental illness and COVID-19
Journal of Nervous and Mental Disease, cilt.209, sa.12, ss.884-891, 2021 (SCI-Expanded, SSCI, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 209 Sayı: 12
- Basım Tarihi: 2021
- Doi Numarası: 10.1097/nmd.0000000000001450
- Dergi Adı: Journal of Nervous and Mental Disease
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus, Academic Search Premier, ATLA Religion Database, BIOSIS, CAB Abstracts, Child Development & Adolescent Studies, CINAHL, Educational research abstracts (ERA), EMBASE, MEDLINE, MLA - Modern Language Association Database, Psycinfo, Violence & Abuse Abstracts
- Sayfa Sayıları: ss.884-891
- Anahtar Kelimeler: Severe mental illness, COVID-19, outcome, schizophrenia, affective disorder
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Recent studies indicated that psychiatric inpatients with severe mental illness (SMI) are at a greater risk of morbidity and mortality from COVID-19. However, there is still little data about the impact of comorbid COVID-19 infection on the course and outcome of acute exacerbations in this population. We conducted a prospective historically matched case control study. The sociodemographic and clinical characteristics of acute psychiatric inpatients with SMI and comorbid COVID-19 (n = 21) were compared with those of historically-matched non-COVID-19 controls with SMI (n = 42). The outcomes for acute inpatients with SMI and COVID-19 were also investigated. The new-onset SMI rate was relatively higher (23.8%) in the COVID-19 group, which has characteristics similar to those of the non-COVID-19 group except for working status (p < 0.05). The COVID-19 group had a high rate of relapse (47.6%) within 6 months of discharge. Our study suggests that patients with SMI who contracted SARS-CoV-2 may have a higher rate of new-onsetmental disorder. Considering the high rate of relapse during the pandemic, chronically ill patients with SMI and COVID-19 should be closely monitored after discharge.